CVS Health to acquire Oak Street Health for $10.6B

The latest stories trending on MedCity News.

Editor's Pick

Top Story Will it? Won't It? CVS Health To Finally Acquire Oak Street Health for $10.6B Rumors of the deal first surfaced in January, with some dismissing the idea. Several experts say the deal makes sense for CVS Health, as it looks to expand into primary and value-based senior care.

Featured News

Expanding Health Equity into Technology: A Preview of the Techquity Conversation at ViVE The newly launched Techquity for Health Coalition from the HLTH Foundation will share findings from its first national survey of techquity at the conference. Healthcare leaders will also discuss on ways to improve health tech design, tech literacy, accessibility, workforce equity, patient trust, and equitable use of data. Apply to MedCity INVEST Pitch Perfect Where Investment Trends and Innovation Converge In the runup to INVEST and the startup pitch contest, we highlight trends in investment and innovation across bipharma, diagnostics, medical devices, health tech: payer/provider, and health tech: consumer/employer. The deadline has been extended until February 28 and finalists will be announced March 31. Apply today! Evernorth: Suicide-related Behavior Is on the Rise for American Youth Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling. A Look at the 5 Companies at the Top of This Year's 'Best in KLAS' Rankings Epic, Nordic, Impact Advisors, The Chartis Group and Medasource were the five companies with the best performances in this year's Best in KLAS Awards. KLAS Research named Epic as the top overall software suite for the thirteenth year in a row. Behavior Hacking, Prevention, and Wellness: Why the Future of Healthcare Still Depends on People No matter how much data the AI has on you, missing is the personal relationship. Emerging tech, wearables—all that is great. But at the end of the day, so much of it still depends on interpersonal relationship building and leveraging, adding an intelligence layer to the loop. Pharma Returns Slump as Post-Pandemic Realities Set In, Deloitte Report Says R&D spending rose in response to Covid-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Deloitte report. California lawsuit targets insulin costs as Biden also takes aim in SOTU High prices have drawn other critics, as well, including President Joe Biden. He renewed his call for a broad price cap during his annual State of the Union address. Pharma companies insist they have been part of the solution.

Resources

AI in Healthcare: Scratching the Surface Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe